Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Dose-matched placebo

Dose-matched placebo was supplied as tablets.

DRUG

Vilazodone

Vilazodone was supplied as tablets.

Trial Locations (14)

19104

Forest Investigative Site 011, Philadelphia

21285

Forest Investigative Site 001, Baltimore

30328

Forest Investigative Site 012, Atlanta

32216

Forest Investigative Site 005, Jacksonville

32806

Forest Investigative Site 004, Orlando

38119

Forest Investigative Site 008, Memphis

45417

Forest Investigative Site 002, Dayton

78229

Forest Investigative Site 016, San Antonio

90210

Forest Investigative Site 009, Beverly Hills

91316

Forest Investigative Site 003, Encino

92660

Forest Investigative Site 010, New Port Beach

98007

Forest Investigative Site 006, Bellevue

98104

Forest Investigative Site 013, Seattle

02865

Forest Investigative Site 015, Lincoln

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY